Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 502M | 640M | 544M | 60M | 60M |
| Gross Profit | 123M | 8M | 239M | 9M | 11M |
| Operating Income | 9M | -2.1B | 131M | -6M | -12M |
| EBITDA | 114M | -211M | 184M | 12M | -5M |
| Net Income | -246M | -2.1B | 47M | -12M | -12M |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$0.89
-29.37% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Core Scientific, Inc. (CORZQ) is a Technology stock with a market cap of $343.56M. The stock last traded around $0.89. Baseline metrics include revenue growth of -21.5%, EPS growth of +89.8%, a dividend yield of 0.0%. What stands out right now is revenue -21.5%, EPS +89.8%, free cash flow +112.1% with operating margin -38.0% and ROIC -7.7%. Valuation already assumes a fairly strong business story at price/sales 22.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CORZQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CORZQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CORZQ Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CORZQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$59.5M
-1.3% YoY
FY Net Income
-$11.9M
+2.3% YoY
Free Cash Flow
-$38.4M
+1.7% YoY
Revenue Growth
-21.5%
EPS Growth
+89.8%
Gross Margin
11.9%
Net Margin
-90.5%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 502M | 640M | 544M | 60M | 60M |
| Gross Profit | 123M | 8M | 239M | 9M | 11M |
| Operating Income | 9M | -2.1B | 131M | -6M | -12M |
| EBITDA | 114M | -211M | 184M | 12M | -5M |
| Net Income | -246M | -2.1B | 47M | -12M | -12M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 50M | 16M | 118M | 9M | 7M |
| Total Assets | 712M | 808M | 2.4B | 226M | 162M |
| Total Liabilities | 1.3B | 1.2B | 1.1B | 136M | 56M |
| Shareholder Equity | -597M | -409M | 1.3B | 89M | 106M |
| Total Debt | 866M | 38M | 819M | 40M | 7M |
| Net Debt | 758M | 22M | 701M | 32M | 837K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
832K
+96.5% YoY
Capital Expenditures
38M
-146.3% YoY
Free Cash Flow
38M
+1.7% YoY
Key ratios
Gross Margin
11.9%
Operating Margin
-38.0%
Net Margin
-90.5%
ROE
34.6%
Debt / Equity
-1.10x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.